Enabled Therapeutics strengthens leadership team as it redefines neurology with on-site drug synthesis and precision brain therapeutics.
Categories
Jivan Achreja, Board of Directors
Jivan Achreja is Co-Founder and CTO of Recombo.AI and ETHOS Scientific, and a veteran technology leader in healthcare and life sciences. He previously held executive roles at Advarra, Medidata Solutions, and YPrime, with expertise in platform innovation, clinical research, and strategic growth. He holds a BS in Biology, Chemistry, and Entrepreneurship from the University of […]
Enabled Therapeutics Gains FDA Alignment for CPT-021: A First-of-Its-Kind Targeted Therapy for Alzheimer’s
Categories
Bruno Hauser | Board of Directors
For more than 30 years working in the Swiss banking business with experience in lending, research, brokerage, asset management and investment banking. Played a key role in funding and the IPO of BioMarin.
Categories
Marcel Gradidge | CBO
20+ Years in Industry and Management Consulting, Advising Senior Executives in Pharma and MedTech on Commercial Strategy, Manufacturing Efficiency, Regulatory Compliance, and Operational Excellence.
New Technology Addresses Brain Trauma Including Alzheimer’s, TBI, and Epilepsy SAN FRANCISCO, Jan. 5, 2024 /PRNewswire-PRWeb/ — Mercaptor Inc, a privately held pharmaceutical company, today announced a breakthrough platform for the CNS. The pivotal technology overcomes challenges that have limited the development of meaningful treatments for the brain. The chemistry improves distribution, proportionates drug activity based on pathology […]
https://www.prnewswire.com/news-releases/mercaptor-discoveries-advances-drug-candidate-to-treat-brain-inflammation-in-people-with-long-covid-301318107.html Mercaptor Discoveries (Mercaptor) today advanced their therapeutic candidate to treat brain-inflammation found in patients with long COVID, also known as post-acute sequelae of COVID-19. Long COVID is characterized by persistent or new symptoms that develop at least four to eight weeks after the initial infection with COVID-19.¹ The company also revealed efficacy and safety data […]
Categories
Dr. Adriano Aguzzi, MD, PhD
Dr. Adriano Aguzzi, MD, PhD, is heading up the formation of Mercaptor’s Scientific Advisory Board (SAB). Dr. Aguzzi is a world-renowned neuropathologist, whose research has garnered numerous accolades including the Marcel-Benoist Prize, the Robert-Koch Prize, the Antonio-Feltrinelli Award and the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, which are among the highest recognitions […]
Paul directs the technical operations at Enabled Therapeutics.